Cessation of alcohol and smoking to prevent acute pancreatitis recurrence
Official title: Recurrent Acute Pancreatitis Prevention by the Elimination of Alcohol and Cigarette Smoking (REAPPEAR): Protocol of a Randomized Controlled Trial and a Cohort Study
Run by University of Pecs · NCT04647097 · Data updated 2026-11-12
This study is testing whether quitting alcohol and smoking can help people who have had acute pancreatitis avoid getting it again.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 364 (estimated) |
| Sponsor | University of Pecs Academic / other |
| Locations | 1 site (Pécs) |
| Status | Recruiting |
| Started | March 1, 2022 |
| Main results expected | December 31, 2027 |
| Study ends | June 30, 2028 |
| Registry record updated | April 26, 2023 |
| Trial ID | NCT04647097 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are daily smokers aged 18-80 who have been hospitalized for alcohol-induced acute pancreatitis.
✕Probably not a fit
Patients with acute pancreatitis caused by factors other than alcohol or those with severe psychiatric illnesses may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of a lifestyle intervention aimed at preventing the recurrence of acute pancreatitis by promoting the cessation of alcohol consumption and smoking. It includes a randomized controlled trial and a cohort analysis to assess the impact of these lifestyle changes on patients hospitalized with alcohol-induced pancreatitis. Participants will receive standard cessation interventions and will be monitored for changes in motivation, addiction, quality of life, and socioeconomic status over time. Laboratory tests and biomarker measurements will also be conducted to evaluate the intervention's efficacy.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce the recurrence of acute pancreatitis in patients who consume alcohol and smoke.
How similar studies have gone: While there is clinical equipoise regarding the impact of alcohol and smoking cessation, this study aims to fill a gap in the literature, as well-designed clinical trials on this topic are lacking.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * Patient hospitalized with alcohol-induced AP (defined by the revised Atlanta criteria 38) * Every day smoker (defined as an adult patient who smoked at least 100 cigarettes in his or her lifetime, and now smokes on a daily basis; as per the CDC definition), with at least 1-year history of smoking * Aged 18-80 years * Provided written informed consent * Willing to participate in the intervention in every three months Exclusion criteria: * Possible etiologies for AP other than alcohol (eg. gallstone-related, hypertriglyceridemia above 11.5 mM 40-42, hypercalcemia, viral infection) if the etiological cannot be terminated during the index admission (lack of same admission cholecystectomy, familiar hypertrygliceridemia) and cases with combined etiological factors will be excluded * Untreated, decompensated or severe mMajor psychiatric illnesses (e.g. schizophrenia, bipolar disorder, dementia) * Currently taking part in a smoking cessation program * Undergoing active or palliative treatment for malignancy * Pregnancy, breastfeeding * Life expectancy is less than two years * Didn't agreed to participate * Other
Where it's running
-
Institute for Translational Medicine, University of Pécs
Pécs, Hungary Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Local complications of acute pancreatitis and postoperative pancreatic fistula: what happens in real life
This multicenter registry tests how local pancreatic complications are managed in routine care and what outcomes look like over 180 days for adults.
-
SGC001 is being tested to help predicted severe acute pancreatitis
Researchers are testing SGC001 vs placebo in adults with predicted severe acute pancreatitis to see if it is safe and tolerable and to get a sense of any early effects.
-
Fecal microbiota transplant to prevent infections after late-phase severe acute pancreatitis
This trial will test whether giving healthy donor gut bacteria (fecal microbiota transplantation) through a feeding tube in the late phase of moderately severe or severe acute pancreatitis can prevent infectious complications.
-
Soy-tomato juice for people with recurrent acute or chronic pancreatitis
This will try giving daily soy-tomato juice to people with recurrent acute or chronic pancreatitis to see if they can tolerate it and whether it reduces inflammation and symptoms.
-
Blood test to find mild-to-moderate pancreatic enzyme insufficiency and guide enzyme treatment for people with pancreatitis
This project will use the Malabsorption Blood Test to find adults with recurrent acute or chronic pancreatitis who have mild-to-moderate exocrine pancreatic insufficiency and see if pancreatic enzyme replacement for responsive patients improves quality of life.
-
How often splanchnic vein clots occur in acute pancreatitis and whether they relate to disease severity
This project will see if people with acute pancreatitis develop blood clots in the splenic, portal, or superior mesenteric veins and whether those clots are linked to more severe illness.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.